A review on captopril oral sustained/controlled release formulations

International Journal of Drug Development and Research

Volumn 2, Issue 2, 2010, Pages 257-264

  Shanthi, C Nithya ^a   Gupta, Rakesh ^a   Mahato, Arun Kumar ^b  

^a Bharat Sewak Shiksha Samiti   (India)

^b Jaipur Natiomal University   (India)

Author keywords

Bioavailability; Captopril; Controlled release formulations

Indexed keywords

ASCORBIC ACID; CAPTOPRIL; CARBOXYMETHYLCELLULOSE; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE;

AREA UNDER THE CURVE; ARTERIAL PRESSURE; CONGESTIVE HEART FAILURE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG GRANULE; DRUG STABILITY; EMULSION; ENTERIC COATED TABLET; HUMAN; HYPERTENSION; IC 50; MATRIX TABLET; MEAN RESIDENCE TIME; MICROCAPSULE; NONHUMAN; OSMOTIC PRESSURE; OSMOTIC PUMP; REVIEW; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

EID: 78650154821     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Dollery C. Therapeutics Drugs, Churchill Livingstone, 1999; pp-38-43.
2. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets; design and release kinetics. Drug dev. Ind. Pharm. 2000a; 26:965-969. (Pubitemid 30471042)
3. Trissel LA. Trissel's stability of compounded formulations. 2000;444.
4. Seta Y, Higuchi F, Kawahara Y, Nishimura K, Okada R. Design and preparation of Captopril sustained release dosage forms and their biopharmaceutical proper ties. Int. J. Pharm. 1988a; 41:245-254. (Pubitemid 18034878)
5. Nur AO, Zhang JS. Recent progress in sustained/controlled oral delivery of Captopril: an overview. Int. J. Pharm. 2000b; 194:139-146. (Pubitemid 30110676)
6. Bolourtchian N, Hadifi N, Foroutan SM, Faghi, BS. Formulation and optimization of captopril sublingual tablet using D-optimal design. Iran. J. Pharm Res. 2008;7:259-67.
7. Al-Saidan SM, Krishnaiah Y S R, Patro SS, Satyanarayana V. Invitro and invivo evaluation of Guar gum matrix tablets for oral controlled release of water soluble Diltiazem Hydrochloride. AAPS. Pharm. Sci. Tech. 2005;6: E14-21. (Pubitemid 41631005)
8. Ojoe E, Miyauchi EM, Kaneko TM, Velasco M V R, Consiglieri VO. Influence of cellulose polymers type on invitro controlled release tablets containing theophylline. Braz. J. Pharm. Sci. 2007;43:572-579.
9. Nokhodchi A, Zadeh DH, Zadeh FM, Zadeh NT. Effect of various surfactants and their concentration on controlled release of Captopril from polymer matrices. Acta. Pharm. 2008;58:151-162. (Pubitemid 351777176)
10. Guittard GV, Carpenter HA, Quan ES, Wong PS, Hamel LG. Dosage form for delivery drug in short time period. 1993; U. S. Patent 5178867:12 Jan.
11. Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. Oral sustained delivery of atenolol from floating matrix tablets-Formulation and invitro evaluation. Drug. Dev. Ind. Pharm. 2005. 31:367-374. (Pubitemid 41289149)
12. Martinez IJ, Barreda TQ, Robles LV. Sustained delivery of captopril from floating matrix tablets. Int. J. Pharm. 2008;362:37-43.
13. Patel P, Dand N, Sonwanshi A, Kadam VJ, Hirlekar RS, Design and evaluation of a sustained release Gastroretentive dosage form of captopril: A technical note. AAPS. Pharm. Sci. Tech. 2008.
14. Rahman Z, Ali M, Khar RK. Design and evaluation of bilayer floating tablets of Captopril. Acta. Pharm. 2006;56:49-57. (Pubitemid 43253972)
15. Meka L, Kesavan B, Chinnala KM, Rao M. Preparation of a matrix type multiple unit Gastroretentive floating drug delivery system for captopril based on gas formation technique:Invitro evaluation. AAPS. Pharm. Sci. Tech. 2008;9:612-619.
16. Khattab I, Rahman SB, Khidr S, Hakiem OA. Development and optimization of sustained release captopril tablets and capsules. AAPS. Pharm. Sci. Tech. 1999.
17. Stulzer HK, Segattosilva MS, Fernandes D, Assreuy J. Development of controlled release captopril granules coated with ethyl cellulose and methyl cellulose by fluid bed drier. Drug. Del. 2008;15:11-18.
18. Seta Y, Higuchi F, Otsuka T, Kawahara Y, Nishimura K, Okada R, Koike H. Preparation and pharmacological evaluation of captopril sustained release dosage forms using oily semisolid matrix. Int. J. Pharm. 1988b; 41:255-262. (Pubitemid 18034879)
19. Seta Y, Otsuka T, Tokiwa H, Naganuma H, Kawahara Y, Nishimura K, Okada R. Design of captopril sustained release preparation with oily semisolid matrix intended for use in human subjects. Int. J. Pharm. 1988c; 41:263-269. (Pubitemid 18034880)
20. Dandagi PM, Mastiholimath VS, Patil M. B, Gupta MK. Biodegradable Microparticulate system of captopril. Int. J. Pharm. 2006;307:83-88. (Pubitemid 41773255)
21. El-Kamel AH, Al-Shora DH, El-Sayed YM. Formulation and pharmacodynamic evaluation of captopril sustained release microparticles. J. MicroEncap. 2006;23:389-404. (Pubitemid 44132548)
22. Harding SE. Mucoadhesive interactions. Biochem. Soc. Trans. 2003;31:1036-1041. (Pubitemid 37305042)
23. Chowdhary K P R, Rao YS. Design and invitro and invivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. AAPS. Pharm. Sci. Tech. 2003;4:1-6.
24. Altaf MA, Sreedharan, Charyulu N. Ionic gelation controlled drug delivery systems for gastric mucoadhesive microcapsules of captopril. Ind. J. Pharm. Sci. 2008;70:655-58.
25. Theewes F. Elementary osmotic pump. J. Pharm Sci. 1975;64:1987-91.
26. Rani M, Surana R, Sankar C, Mishra B. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium. Acta Pharm. 2003;53:263-273. (Pubitemid 38083941)
27. Okimoto K, Rajewski RA, Stella VJ. Release of testosterone from an osmotic pump tablet utilizing (SBE) 7m-β-cyclodextrin as both a solubilizer and osmotic agent. J. Contrl. Rel. 1999;58:29-38. (Pubitemid 29371811)
28. Li XD, Pan WS, Nie SF, Wu LJ. Studies on controlled release effervescent osmotic pump tablets from traditional Chinese medicine compound recipe. J. Contrl. Rel. 2004;96:359-367.
29. Xu L, Li S, Sunada H. Preparation and evaluation of invitro and invivo of captopril elementary osmotic pump tablets. Asian J Pharm Sci. 2006;1:236-245.